Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) has issued an update.
Cochlear Limited has announced the application for the quotation of 1,774 ordinary fully paid securities on the Australian Securities Exchange (ASX), with the issue date set for August 18, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its growth initiatives, potentially impacting its market positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in the development and distribution of implantable hearing solutions. The company’s primary products include cochlear implants, bone conduction implants, and acoustic implants, catering to individuals with moderate to profound hearing loss. Cochlear is a leading player in the global hearing solutions market, focusing on innovation and improving the quality of life for those with hearing impairments.
Average Trading Volume: 173,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.4B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.